title: Improved outcome of adults with aplastic anaemia treated with arsenic trioxide plus ciclosporin.
authors.forename: Yongping
authors.initials: Y
authors.lastname: Song
authors.forename: Ning
authors.initials: N
authors.lastname: Li
authors.forename: Yuzhang
authors.initials: Y
authors.lastname: Liu
authors.forename: Baijun
authors.initials: B
authors.lastname: Fang
mesh_terms: D050156:Adipogenesis / Q000187:drug effects; D000328:Adult; D000741:Anemia, Aplastic / Q000097:blood / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001772:Blood Cell Count; D001803:Blood Transfusion; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D059630:Mesenchymal Stem Cells / Q000187:drug effects / Q000473:pathology; D010087:Oxides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012074:Remission Induction; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D001152:Arsenicals; D010087:Oxides; D016572:Cyclosporine; D000077237:Arsenic Trioxide